Medex (Group) Ltd - Accounts to registrar (filleted) - small 18.2

Medex (Group) Ltd - Accounts to registrar (filleted) - small 18.2


IRIS Accounts Production v22.1.0.628 07342917 Board of Directors 1.9.20 31.8.21 31.8.21 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure073429172020-08-31073429172021-08-31073429172020-09-012021-08-31073429172019-08-31073429172019-09-012020-08-31073429172020-08-3107342917ns16:EnglandWales2020-09-012021-08-3107342917ns15:PoundSterling2020-09-012021-08-3107342917ns11:Director12020-09-012021-08-3107342917ns11:PrivateLimitedCompanyLtd2020-09-012021-08-3107342917ns11:SmallEntities2020-09-012021-08-3107342917ns11:AuditExempt-NoAccountantsReport2020-09-012021-08-3107342917ns11:SmallCompaniesRegimeForDirectorsReport2020-09-012021-08-3107342917ns11:SmallCompaniesRegimeForAccounts2020-09-012021-08-3107342917ns11:FullAccounts2020-09-012021-08-310734291712020-09-012021-08-3107342917ns11:Director22020-09-012021-08-3107342917ns11:RegisteredOffice2020-09-012021-08-3107342917ns6:CurrentFinancialInstruments2021-08-3107342917ns6:CurrentFinancialInstruments2020-08-3107342917ns6:Non-currentFinancialInstruments2021-08-3107342917ns6:Non-currentFinancialInstruments2020-08-3107342917ns6:ShareCapital2021-08-3107342917ns6:ShareCapital2020-08-3107342917ns6:RetainedEarningsAccumulatedLosses2021-08-3107342917ns6:RetainedEarningsAccumulatedLosses2020-08-3107342917ns6:IntangibleAssetsOtherThanGoodwill2020-09-012021-08-3107342917ns6:DevelopmentCostsCapitalisedDevelopmentExpenditure2020-09-012021-08-3107342917ns6:PlantMachinery2020-09-012021-08-3107342917ns6:IntangibleAssetsOtherThanGoodwill2020-08-3107342917ns6:IntangibleAssetsOtherThanGoodwill2021-08-3107342917ns6:IntangibleAssetsOtherThanGoodwill2020-08-3107342917ns6:LandBuildings2020-08-3107342917ns6:PlantMachinery2020-08-3107342917ns6:LandBuildings2020-09-012021-08-3107342917ns6:LandBuildings2021-08-3107342917ns6:PlantMachinery2021-08-3107342917ns6:LandBuildings2020-08-3107342917ns6:PlantMachinery2020-08-3107342917ns6:CostValuation2020-08-3107342917ns6:CurrentFinancialInstrumentsns6:WithinOneYear2021-08-3107342917ns6:CurrentFinancialInstrumentsns6:WithinOneYear2020-08-31
REGISTERED NUMBER: 07342917 (England and Wales)















Unaudited Financial Statements for the Year Ended 31 August 2021

for

Medex (Group) Ltd

Medex (Group) Ltd (Registered number: 07342917)

Contents of the Financial Statements
for the year ended 31 August 2021










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Medex (Group) Ltd

Company Information
for the year ended 31 August 2021







DIRECTORS: Ms R A Brownrigg
Ms A Fletcher





REGISTERED OFFICE: Botanical Gardens Business Centre
3 Southbourne Road
Sheffield
S10 2QN





REGISTERED NUMBER: 07342917 (England and Wales)





ACCOUNTANTS: Marshall & Co
Chartered Accountants
& Chartered Tax Advisers
The Bloc
Springfield Way
Anlaby
Kingston upon Hull
East Yorkshire
HU10 6RJ

Medex (Group) Ltd (Registered number: 07342917)

Balance Sheet
31 August 2021

2021 2020
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 118,176 118,176
Tangible assets 5 857,203 713,588
Investments 6 2 2
975,381 831,766

CURRENT ASSETS
Debtors 7 205,640 105,277
Cash at bank and in hand 17,306 53,819
222,946 159,096
CREDITORS
Amounts falling due within one year 8 292,495 74,164
NET CURRENT (LIABILITIES)/ASSETS (69,549 ) 84,932
TOTAL ASSETS LESS CURRENT
LIABILITIES

905,832

916,698

CREDITORS
Amounts falling due after more than one
year

9

769,152

824,240
NET ASSETS 136,680 92,458

CAPITAL AND RESERVES
Called up share capital 1 1
Retained earnings 136,679 92,457
136,680 92,458

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 August 2021.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 August 2021 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Medex (Group) Ltd (Registered number: 07342917)

Balance Sheet - continued
31 August 2021


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 29 August 2022 and were signed on its behalf by:





Ms R A Brownrigg - Director


Medex (Group) Ltd (Registered number: 07342917)

Notes to the Financial Statements
for the year ended 31 August 2021


1. STATUTORY INFORMATION

Medex (Group) Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Development costs are being amortised evenly over their estimated useful life of five years.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 33% on cost and 20% on cost

Investments in subsidiaries
Investments in subsidiary undertakings are recognised at cost.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Medex (Group) Ltd (Registered number: 07342917)

Notes to the Financial Statements - continued
for the year ended 31 August 2021


2. ACCOUNTING POLICIES - continued

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 10 (2020 - 10 ) .

4. INTANGIBLE FIXED ASSETS
Other
intangible
assets
£   
COST
At 1 September 2020
and 31 August 2021 118,176
NET BOOK VALUE
At 31 August 2021 118,176
At 31 August 2020 118,176

5. TANGIBLE FIXED ASSETS
Plant and
Land and machinery
buildings etc Totals
£    £    £   
COST
At 1 September 2020 709,400 71,352 780,752
Additions 82,027 84,352 166,379
At 31 August 2021 791,427 155,704 947,131
DEPRECIATION
At 1 September 2020 - 67,164 67,164
Charge for year - 22,764 22,764
At 31 August 2021 - 89,928 89,928
NET BOOK VALUE
At 31 August 2021 791,427 65,776 857,203
At 31 August 2020 709,400 4,188 713,588

Medex (Group) Ltd (Registered number: 07342917)

Notes to the Financial Statements - continued
for the year ended 31 August 2021


6. FIXED ASSET INVESTMENTS
Shares in
group
undertakings
£   
COST
At 1 September 2020
and 31 August 2021 2
NET BOOK VALUE
At 31 August 2021 2
At 31 August 2020 2

7. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2021 2020
£    £   
Trade debtors 20,135 11,880
Other debtors 185,505 93,397
205,640 105,277

8. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2021 2020
£    £   
Bank loans and overdrafts 34,250 33,762
Hire purchase contracts 30,236 -
Trade creditors 71,656 11,917
Taxation and social security 27,948 20,161
Other creditors 128,405 8,324
292,495 74,164

9. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2021 2020
£    £   
Bank loans 769,152 824,240

Amounts falling due in more than five years:

Repayable by instalments
Bank loans more 5 yr by instal 475,000 582,739

10. RELATED PARTY DISCLOSURES

During the year, total dividends of £110,750 were paid to the directors .

11. ULTIMATE CONTROLLING PARTY

The controlling party is Ms R A Brownrigg.